Clinical Trial Update: Intrathecal Double Checkpoint Inhibition [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial from the University of Zurich investigates intrathecal double checkpoint inhibition for leptomeningeal metastasis and advanced cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Zurich | Conditions: Leptomeningeal Metastasis, Non-small Cell Lung Cancer Stage IV | Phase 1 | Status: ACTIVE_NOT_RECRUITING